Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 31, 2024

SELL
$0.28 - $1.16 $207,260 - $858,651
-740,217 Reduced 84.62%
134,583 $45,000
Q1 2024

May 07, 2024

SELL
$1.06 - $1.67 $177,020 - $278,890
-167,000 Reduced 16.03%
874,800 $1.02 Million
Q4 2023

Feb 01, 2024

SELL
$1.26 - $1.79 $157,623 - $223,925
-125,098 Reduced 10.72%
1,041,800 $1.76 Million
Q3 2023

Nov 07, 2023

SELL
$1.61 - $2.54 $306,238 - $483,133
-190,210 Reduced 14.02%
1,166,898 $2.11 Million
Q2 2023

Aug 07, 2023

BUY
$1.14 - $1.95 $584,373 - $999,585
512,608 Added 60.7%
1,357,108 $2.52 Million
Q3 2022

Nov 08, 2022

SELL
$0.73 - $3.74 $24,382 - $124,916
-33,400 Reduced 3.8%
844,500 $2.64 Million
Q2 2022

Aug 04, 2022

BUY
$2.2 - $4.2 $1.93 Million - $3.69 Million
877,900 New
877,900 $2.09 Million

Others Institutions Holding DNA

About Ginkgo Bioworks Holdings, Inc.


  • Ticker DNA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 1,287,779,968
  • Market Cap $12.1B
  • Description
  • Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...
More about DNA
Track This Portfolio

Track New York State Common Retirement Fund Portfolio

Follow New York State Common Retirement Fund and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on New York State Common Retirement Fund with notifications on news.